RC-160 (Vapreotide) (CAS 103222-11-3)

RC-160, also known as Vapreotide, has emerged as a valuable tool in scientific research due to its ability to selectively activate somatostatin receptors. This synthetic peptide derivative exhibits high affinity for somatostatin receptor subtype 2 (SST2), effectively modulating cellular signaling pathways associated with this receptor. Through its interaction with SST2, RC-160 regulates various physiological processes, including hormone secretion, neurotransmission, and cell proliferation. Research has utilized RC-160 to investigate the role of somatostatin signaling in neuroendocrine regulation, tumor growth inhibition, and immune modulation. Moreover, RC-160 has been instrumental in elucidating the molecular mechanisms underlying somatostatin receptor activation and downstream intracellular signaling cascades. Furthermore, the development of RC-160 analogs and derivatives has enabled researchers to optimize its pharmacological properties, enhance receptor selectivity, and explore its potential applications in targeted drug delivery and imaging techniques. Overall, RC-160 holds promise as a valuable research tool for unraveling the complexities of somatostatin signaling and its implications in various physiological and pathological conditions, offering insights into potential interventions and diagnostic approaches.